ATE294391T1 - Methode mit hohem durchsatz - Google Patents

Methode mit hohem durchsatz

Info

Publication number
ATE294391T1
ATE294391T1 AT98930081T AT98930081T ATE294391T1 AT E294391 T1 ATE294391 T1 AT E294391T1 AT 98930081 T AT98930081 T AT 98930081T AT 98930081 T AT98930081 T AT 98930081T AT E294391 T1 ATE294391 T1 AT E294391T1
Authority
AT
Austria
Prior art keywords
bound
high throughput
solid supports
inhibition
assay
Prior art date
Application number
AT98930081T
Other languages
English (en)
Inventor
Jonathan J Burbaum
Thomas D Y Chung
Gregory L Kirk
James Inglese
Daniel Chelsky
Original Assignee
Pharmacopeia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25351362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE294391(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacopeia Inc filed Critical Pharmacopeia Inc
Application granted granted Critical
Publication of ATE294391T1 publication Critical patent/ATE294391T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Steroid Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT98930081T 1997-06-03 1998-06-01 Methode mit hohem durchsatz ATE294391T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/868,280 US5876946A (en) 1997-06-03 1997-06-03 High-throughput assay
PCT/US1998/011749 WO1998055866A1 (en) 1997-06-03 1998-06-01 High-throughput assay

Publications (1)

Publication Number Publication Date
ATE294391T1 true ATE294391T1 (de) 2005-05-15

Family

ID=25351362

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98930081T ATE294391T1 (de) 1997-06-03 1998-06-01 Methode mit hohem durchsatz

Country Status (8)

Country Link
US (2) US5876946A (de)
EP (1) EP1002233B1 (de)
JP (1) JP4007459B2 (de)
AT (1) ATE294391T1 (de)
AU (1) AU741376B2 (de)
CA (1) CA2291621A1 (de)
DE (1) DE69829973T2 (de)
WO (1) WO1998055866A1 (de)

Families Citing this family (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251691B1 (en) 1996-04-25 2001-06-26 Bioarray Solutions, Llc Light-controlled electrokinetic assembly of particles near surfaces
AU3122497A (en) * 1996-05-14 1997-12-05 University Of Manitoba Solid-phase activity assay for biologically active substance
US6171780B1 (en) 1997-06-02 2001-01-09 Aurora Biosciences Corporation Low fluorescence assay platforms and related methods for drug discovery
US6517781B1 (en) * 1997-06-02 2003-02-11 Aurora Biosciences Corporation Low fluorescence assay platforms and related methods for drug discovery
US5876946A (en) * 1997-06-03 1999-03-02 Pharmacopeia, Inc. High-throughput assay
US6833242B2 (en) * 1997-09-23 2004-12-21 California Institute Of Technology Methods for detecting and sorting polynucleotides based on size
DE69836092T2 (de) * 1997-10-24 2007-05-10 Invitrogen Corp., Carlsbad Rekombinatorisches klonieren unter verwendung von nukleinsaüren mit rekombinationsstellen
US6242262B1 (en) 1997-10-24 2001-06-05 The University Of North Carolina At Chapel Hill Method and apparatus for screening catalyst libraries
US7321023B2 (en) * 1997-11-07 2008-01-22 Incyte Corporation SP16 protein
US6790652B1 (en) * 1998-01-08 2004-09-14 Bioimage A/S Method and apparatus for high density format screening for bioactive molecules
US6861035B2 (en) * 1998-02-24 2005-03-01 Aurora Discovery, Inc. Multi-well platforms, caddies, lids and combinations thereof
US20030036855A1 (en) * 1998-03-16 2003-02-20 Praelux Incorporated, A Corporation Of New Jersey Method and apparatus for screening chemical compounds
US6388788B1 (en) 1998-03-16 2002-05-14 Praelux, Inc. Method and apparatus for screening chemical compounds
US6274088B1 (en) * 1998-04-06 2001-08-14 Pharmacopeia, Inc. Methods and apparatus for high throughput plate to plate or plate to membrane transfer
US6083486A (en) * 1998-05-14 2000-07-04 The General Hospital Corporation Intramolecularly-quenched near infrared fluorescent probes
US6592847B1 (en) * 1998-05-14 2003-07-15 The General Hospital Corporation Intramolecularly-quenched near infrared flourescent probes
US6362371B1 (en) * 1998-06-08 2002-03-26 Advanced Medicine, Inc. β2- adrenergic receptor agonists
US6190667B1 (en) * 1998-06-30 2001-02-20 Institut Pasteur Methods of inhibiting Helicobacter pylori
JP4415093B2 (ja) * 1998-07-22 2010-02-17 独立行政法人産業技術総合研究所 標識化複合体並びにその製造方法及び使用方法
EP1131425A2 (de) 1998-11-18 2001-09-12 Incyte Pharmaceuticals, Inc. Gene, die mit entzündungen verbunden sind
US7510841B2 (en) * 1998-12-28 2009-03-31 Illumina, Inc. Methods of making and using composite arrays for the detection of a plurality of target analytes
US20040185432A1 (en) * 1999-01-08 2004-09-23 Bioimage A/S Method and apparatus for high density format screening for bioactive molecules
JP3649319B2 (ja) * 1999-01-25 2005-05-18 東洋紡績株式会社 レセプター結合能の測定方法および測定用試薬
DE19903576C2 (de) 1999-01-29 2001-02-22 Bodenseewerk Perkin Elmer Co Quantitative Bestimmung von Analyten in einem heterogenen System
US20030096433A1 (en) * 1999-03-03 2003-05-22 Evotec Analytical Systems Gmbh Homogeneous fluorescence assay
US7105315B2 (en) * 1999-06-16 2006-09-12 Incyte Genomics, Inc. Transmembrane protein differentially expressed in cancer
US7932213B2 (en) * 1999-05-11 2011-04-26 President And Fellows Of Harvard College Small molecule printing
US6824987B1 (en) 1999-05-11 2004-11-30 President And Fellows Of Harvard College Small molecule printing
CA2378687A1 (en) * 1999-06-18 2000-12-28 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome
US6140500A (en) * 1999-09-03 2000-10-31 Pe Corporation Red-emitting [8,9]benzophenoxazine nucleic acid dyes and methods for their use
US20050069956A1 (en) * 1999-11-22 2005-03-31 Michael Seul Color-encoding and in-situ interrogation of matrix-coupled chemical compounds
AU2001249738A1 (en) * 2000-03-31 2001-10-15 Glaxo Group Limited Method and reagents for investigating functional molecular interactions
IL151828A0 (en) * 2000-04-03 2003-04-10 Bristol Myers Squibb Pharma Co Proteins having gamma-secretase activity and methods for isolating the same and methods detecting said activity
AU7299301A (en) 2000-06-21 2002-01-02 Bioarray Solutions Ltd Multianalyte molecular analysis using application-specific random particle arrays
US9709559B2 (en) 2000-06-21 2017-07-18 Bioarray Solutions, Ltd. Multianalyte molecular analysis using application-specific random particle arrays
US20040235173A1 (en) * 2000-07-03 2004-11-25 Gala Design, Inc. Production of host cells containing multiple integrating vectors by serial transduction
AU2001270252B2 (en) * 2000-07-03 2007-02-08 Catalent Pharma Solutions, Llc Expression vectors
US20030224415A1 (en) * 2001-06-29 2003-12-04 Gala Design, Inc. Selection free growth of host cells containing multiple integrating vectors
US6852510B2 (en) 2000-07-03 2005-02-08 Gala Design Inc Host cells containing multiple integrating vectors
US20020146741A1 (en) * 2000-07-28 2002-10-10 Halbleib Cale M. Processes for receptpor screening
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
DE10045808C2 (de) * 2000-09-07 2002-08-08 Imb Inst Fuer Molekulare Biote Verfahren zur Detektion der Aktivität von Wirkstoffen
AU2002230524A1 (en) * 2000-11-16 2002-05-27 California Institute Of Technology Apparatus and methods for conducting assays and high throughput screening
US7383076B2 (en) * 2000-11-27 2008-06-03 The General Hospital Corporation Fluorescence-mediated molecular tomography
EP1349546A2 (de) * 2000-12-20 2003-10-08 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Dissoziierte glucocorticoid-rezeptorantagonisten zur behandlung von nebenwirkungen von glucocorticoiden
US20030044353A1 (en) * 2001-01-05 2003-03-06 Ralph Weissleder Activatable imaging probes
US20020123068A1 (en) * 2001-01-31 2002-09-05 Dwyer Brian P. Water-soluble, fluorescent, & electrophoretically mobile peptidic substrates for enzymatic reactions and methods for their use in high-throughput screening assays
EP1239284A1 (de) * 2001-03-08 2002-09-11 The Technology Partnership Public Limited Company Nicht-trennender Testverfahren und System mit opaken Partikeln
AU2002307152A1 (en) 2001-04-06 2002-10-21 California Institute Of Technology Nucleic acid amplification utilizing microfluidic devices
WO2002082082A2 (en) * 2001-04-09 2002-10-17 Boehringer Ingelheim Pharmaceuticals, Inc. Fluorescence polarization assay
US7262063B2 (en) 2001-06-21 2007-08-28 Bio Array Solutions, Ltd. Directed assembly of functional heterostructures
ES2712173T3 (es) 2001-10-15 2019-05-09 Bioarray Solutions Ltd Análisis multiplexado de loci polimórficos mediante consulta simultánea y detección mediada por enzimas
US7871619B2 (en) * 2001-11-30 2011-01-18 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7442512B2 (en) * 2001-11-30 2008-10-28 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7253007B2 (en) * 2001-11-30 2007-08-07 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
EP1463796B1 (de) 2001-11-30 2013-01-09 Fluidigm Corporation Mikrofluidische vorrichtung und verfahren zu ihrer verwendung
US7413866B2 (en) * 2001-11-30 2008-08-19 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7384738B2 (en) * 2002-03-28 2008-06-10 Bremel Robert D Retrovirus-based genomic screening
US20040038304A1 (en) * 2002-03-28 2004-02-26 Gala Design, Inc. Antibody libraries
US7312085B2 (en) * 2002-04-01 2007-12-25 Fluidigm Corporation Microfluidic particle-analysis systems
EP1499706A4 (de) * 2002-04-01 2010-11-03 Fluidigm Corp Mikrofluidische partikelanalysesysteme
NZ535952A (en) 2002-04-04 2009-01-31 Coley Pharm Gmbh Immunostimulatory G,U-containing oligoribonucleotides
EP1504248A1 (de) * 2002-05-10 2005-02-09 Applera Corporation Abbildendes system zur verkleinerung interstitieller bildregionen und dessen verfahren
US20030228621A1 (en) * 2002-05-24 2003-12-11 Yong Qin Common ligand universal enzyme assay and compositions for use therein
US20060086309A1 (en) * 2002-06-24 2006-04-27 Fluiding Corporation Recirculating fluidic network and methods for using the same
CA2494033A1 (en) * 2002-08-01 2004-02-12 Merck & Co., Inc. Novel procedure for growth, imaging, and enumeration of microbial colonies for serological or screening assays
EP1546162B1 (de) 2002-09-20 2011-06-22 Promega Corporation Auf lumineszenz basierende verfahren und sonden zur messung der cytochrom-p450-aktivität
CA2500283A1 (en) 2002-09-25 2004-04-08 California Institute Of Technology Microfluidic large scale integration
JP5695287B2 (ja) 2002-10-02 2015-04-01 カリフォルニア インスティテュート オブ テクノロジー 微小流体の核酸解析
WO2004047007A1 (en) 2002-11-15 2004-06-03 Bioarray Solutions, Ltd. Analysis, secure access to, and transmission of array images
ATE427933T1 (de) * 2002-12-20 2009-04-15 Chemocentryx Inc Inhibitoren der bindungder chemokine i-tac bzw. sdf-1 an den ccxckr2-rezeptor
US20040185445A1 (en) * 2003-03-19 2004-09-23 Ye Fang Universal readout for target identification using biological microarrays
US7604965B2 (en) 2003-04-03 2009-10-20 Fluidigm Corporation Thermal reaction device and method for using the same
WO2005029705A2 (en) 2003-09-18 2005-03-31 Bioarray Solutions, Ltd. Number coding for identification of subtypes of coded types of solid phase carriers
PT1664722E (pt) 2003-09-22 2011-12-28 Bioarray Solutions Ltd Polielectrólito imobilizado à superfície com grupos funcionais múltiplos capazes de se ligarem covalentemente às biomoléculas
US20050142608A1 (en) * 2003-09-22 2005-06-30 Yokogawa Electric Corporation Screening method and device, and new drug screening method and device
EP1692298A4 (de) 2003-10-28 2008-08-13 Bioarray Solutions Ltd Optimierung der genexpressionsanalyse unter verwendung immobilisierter fängersonden
WO2005045060A2 (en) 2003-10-29 2005-05-19 Bioarray Solutions, Ltd. Multiplexed nucleic acid analysis by fragmentation of double-stranded dna
US20100247540A1 (en) * 2003-10-30 2010-09-30 Chemocentryx, Inc. Methods and Compositions For Modulating Angiogenesis
DE602004027538D1 (de) * 2003-12-01 2010-07-15 Life Technologies Corp Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
US20050221429A1 (en) * 2004-01-16 2005-10-06 Cardinal Health Pts, Llc Host cells containing multiple integrating vectors comprising an amplifiable marker
US7848889B2 (en) 2004-08-02 2010-12-07 Bioarray Solutions, Ltd. Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
US20090305321A1 (en) * 2005-03-23 2009-12-10 Astrazeneca Ab Assays for Allosteric Modulators of G-Protein Coupled Receptors (GPCRs)
US20060246576A1 (en) * 2005-04-06 2006-11-02 Affymetrix, Inc. Fluidic system and method for processing biological microarrays in personal instrumentation
DK1871804T3 (da) * 2005-04-21 2013-12-02 Chemocentryx Inc Antistoffer, der binder CCX-CKR2
AU2006241149A1 (en) * 2005-04-26 2006-11-02 Coley Pharmaceutical Gmbh Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
EP2778234B1 (de) 2005-05-31 2017-09-27 Promega Corporation Luminogene und fluorogene verbindungen und verfahren für den nachweis von molekülen oder leiden
US8486629B2 (en) 2005-06-01 2013-07-16 Bioarray Solutions, Ltd. Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation
US7718131B2 (en) * 2005-07-06 2010-05-18 Genetix Limited Methods and apparatus for imaging and processing of samples in biological sample containers
US8822206B2 (en) * 2005-10-11 2014-09-02 The Johns Hopkins University Device for high-throughput stimulation, immunostaining, and visualization of single cells
US8449837B2 (en) * 2005-10-11 2013-05-28 The Johns Hopkins University Microfluidic device for high-throughput cellular gradient and dose response studies
RU2008115455A (ru) * 2005-11-03 2009-12-10 Рэдпойнт Био Корпорэйшн (Us) Высокопроизводительный скрининг-анализ ионного канала trpm5
WO2008013569A2 (en) * 2006-01-03 2008-01-31 The President And Fellows Of Harvard College Small molecule printing
US20090170091A1 (en) * 2006-01-17 2009-07-02 Kenneth Giuliano Method For Predicting Biological Systems Responses
US7815868B1 (en) * 2006-02-28 2010-10-19 Fluidigm Corporation Microfluidic reaction apparatus for high throughput screening
CN101484806A (zh) 2006-05-17 2009-07-15 协乐民公司 一种对组织进行自动分析的方法
US20080003667A1 (en) * 2006-05-19 2008-01-03 Affymetrix, Inc. Consumable elements for use with fluid processing and detection systems
CA2668410C (en) * 2006-11-02 2017-05-16 Mitchell A. Winnik Particles containing detectable elemental code
EP2095119A2 (de) * 2006-11-10 2009-09-02 Cellumen, Inc. Biosensoren für protein-protein-interaktion und verfahren zu ihrer verwendung
US8530181B2 (en) * 2007-11-15 2013-09-10 Eisai R&D Management Co., Ltd. Method of screening for compounds which affect the cleavage of EphA7 byγ-secretase
US7892769B2 (en) 2007-11-30 2011-02-22 Eisai R&D Management Co., Ltd. Processing of EphA4 polypeptide by γ-secretase activity
EP2244741B1 (de) 2008-01-18 2015-03-25 VisEn Medical, Inc. Fluoreszierende bildgebungsmittel
WO2010021686A1 (en) * 2008-08-18 2010-02-25 Promega Corporation Luminogenic compounds and methods to detect cytochrome p450 3a enzymes
EP2497498A4 (de) 2009-11-05 2013-04-17 Univ Osaka Therapeutischer wirkstoff für autoimmunerkrankungen oder allergien sowie verfahren zum screening nach dem therapeutischen wirkstoff
WO2012081502A1 (ja) 2010-12-17 2012-06-21 エーザイ・アール・アンド・ディー・マネジメント株式会社 ゼラチナーゼによるEphA4の切断反応を指標としたスクリーニング方法
ES2739623T3 (es) 2011-03-17 2020-02-03 Cernostics Inc Sistemas y composiciones para diagnosticar el esófago de Barrett y métodos para usarlos
US9784751B2 (en) 2011-04-25 2017-10-10 Eisai R&D Management Co., Ltd. Method for detecting neurological disease associated with cognitive impairment by measuring EphA4 extracellular domain
US9790537B2 (en) 2014-01-29 2017-10-17 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
DE102017114537A1 (de) * 2017-06-29 2019-01-03 Endress+Hauser Conducta Gmbh+Co. Kg Sensormembran, Sensorkappe und optischer Sensor
EP3995582B1 (de) 2019-07-01 2026-04-22 Eisai R&D Management Co., Ltd. Anti-epha4-antikörper
KR20220084035A (ko) * 2019-10-17 2022-06-21 유니버시티 오브 코펜하겐 Tacr2의 효능제

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568649A (en) * 1983-02-22 1986-02-04 Immunex Corporation Immediate ligand detection assay
US5032720A (en) * 1988-04-21 1991-07-16 White John G Confocal imaging system
DE02012428T1 (de) * 1988-07-13 2005-12-15 Optiscan Pty. Ltd., Toorak Konfokales Rastermikroskop
US5274240A (en) * 1990-01-12 1993-12-28 The Regents Of The University Of California Capillary array confocal fluorescence scanner and method
US5091652A (en) * 1990-01-12 1992-02-25 The Regents Of The University Of California Laser excited confocal microscope fluorescence scanner and method
GB9015793D0 (en) * 1990-07-18 1990-09-05 Medical Res Council Confocal scanning optical microscope
US5260578A (en) * 1991-04-10 1993-11-09 Mayo Foundation For Medical Education And Research Confocal imaging system for visible and ultraviolet light
WO1994016718A1 (en) * 1991-07-08 1994-08-04 Neurospheres Ltd. Genetic modification of neural stem cells
US5210636A (en) * 1991-07-19 1993-05-11 Baer Stephen C Rotational oscillatory optical scanning device
US5162941A (en) * 1991-07-23 1992-11-10 The Board Of Governors Of Wayne State University Confocal microscope
US5351152A (en) * 1991-07-23 1994-09-27 The Board Of Governers Of Wayne State University Direct-view stereoscopic confocal microscope
US5114477A (en) * 1991-09-03 1992-05-19 Xerox Corporation Liquid ink compositions
US5323079A (en) * 1992-04-15 1994-06-21 Westinghouse Electric Corp. Half-coil configuration for stator
JP3474589B2 (ja) * 1992-04-17 2003-12-08 株式会社デンソー 相補型ｍｉｓトランジスタ装置
US5313079A (en) * 1992-06-22 1994-05-17 Vlsi Technology, Inc. Gate array bases with flexible routing
US5355215A (en) * 1992-09-30 1994-10-11 Environmental Research Institute Of Michigan Method and apparatus for quantitative fluorescence measurements
US5556764A (en) * 1993-02-17 1996-09-17 Biometric Imaging, Inc. Method and apparatus for cell counting and cell classification
US5547849A (en) * 1993-02-17 1996-08-20 Biometric Imaging, Inc. Apparatus and method for volumetric capillary cytometry
WO1996010090A1 (en) * 1994-09-29 1996-04-04 Merck & Co., Inc. A high capacity screen for immunoregulants
DE4435727A1 (de) * 1994-10-06 1996-04-11 Boehringer Mannheim Gmbh Bindematrix und Analyseelement zur Simultananalyse verschiedener Analyte
DE19631395A1 (de) * 1996-08-02 1998-02-05 Basf Ag Verfahren zum Wirkstoff-Screening
WO1998029736A1 (en) * 1996-12-31 1998-07-09 Genometrix Incorporated Multiplexed molecular analysis apparatus and method
US5876946A (en) * 1997-06-03 1999-03-02 Pharmacopeia, Inc. High-throughput assay
GB9718477D0 (en) * 1997-09-02 1997-11-05 Photonic Research Systems Limi Luminescence detection
BR9908767B1 (pt) * 1998-03-16 2011-09-06 sistema de formação de imagem confocal, sistema de focalização para uso com um substrato, e, processos de examinar um objeto, e de focalização para uso com um substrato.

Also Published As

Publication number Publication date
EP1002233B1 (de) 2005-04-27
JP4007459B2 (ja) 2007-11-14
US5876946A (en) 1999-03-02
DE69829973T2 (de) 2006-03-09
AU741376B2 (en) 2001-11-29
DE69829973D1 (de) 2005-06-02
EP1002233A4 (de) 2002-06-26
EP1002233A1 (de) 2000-05-24
US6156520A (en) 2000-12-05
CA2291621A1 (en) 1998-12-10
WO1998055866A1 (en) 1998-12-10
JP2002511140A (ja) 2002-04-09
AU7955198A (en) 1998-12-21

Similar Documents

Publication Publication Date Title
DE69829973D1 (de) Methode mit hohem durchsatz
GB9903555D0 (en) Chemical and biological assay method and apparatus
WO2002035260A3 (en) Light detection device
DK1131471T3 (da) Et system til cellebaseret screening
WO2000050872A3 (en) A system for cell-based screening
WO2000017643A3 (en) A system for cell-based screening
WO2009038668A3 (en) Highly multiplexed confocal detection systems and methods of using same
GR3032843T3 (en) Methods and compositions for detecting binding of ligand pair using non-fluorescent label
DK0529065T3 (da) Receptorbaserede fremgangsmåder til screening for amylinagonister og -antagonister
WO2004039489A3 (en) Computer programs,workstations, systems and methods for microfluidic substrates in cell
WO1998010068A3 (en) Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
DK0983498T3 (da) System for cellebaseret screening
DK0921857T3 (da) Flerbröndsplader med lav baggrund til fluorescensmålinger af biologiske og biokemiske pröver
ATE461450T1 (de) Verwendung von kontrollflächen zur detektion von störproben in einem nachweisverfahren
BR9305780A (pt) Processo para a determinação de homocisteina em uma amostra e conjunto analitico para uso na determinação de homocisteina em uma amostra
WO2000007017A3 (en) Method of high-throughput screening
Nakajima et al. Capillary affinity electrophoresis for the screening of post-translational modification of proteins with carbohydrates
WO2001011341A3 (en) A system for cell-based screening
ATE545019T1 (de) Mikrofluidisches extraktionsverfahren
WO2000070342A3 (en) Optical system analysis of cells
CA2473708A1 (en) A rapid and sensitive assay for the detection and quantification of coregulators of nucleic acid binding factors
Edwards Immunodiagnostics: a practical approach
EP1310794A3 (de) Antikörpertestverfahren und Antigenmikroarray
WO2002072789A3 (en) Genomics-driven high speed cellular assays, development thereof, and collections of cellular reporters
WO2007047149A3 (en) Susceptibility-matched multi-well sample holders for high-throughput screening by magnetic analysis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties